Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水素是不恰当的，很少有超过急性足痛风的病人了，并且秋水素导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水治疗效果不明显转而受氨苯砜治疗的患者应当继续服用秋水。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水仙素是不恰当，很少有炎症能超过急性足痛风病人，秋水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱效果不明显转而受氨苯砜患者应当继续服用秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口秋水仙素是不恰当的，很少有炎症能超过痛风的病人了，并且秋水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治疗效果不明显转而受氨苯砜治疗的患者应当继秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水仙素是不恰当的，很少有炎症能超急性足痛风的病了，并且秋水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治疗效果不明显转而受氨苯砜治疗的患者应当继续服用秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

水仙素是不恰当的，很少有炎症能超过急性足痛风的病人了，并且水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受水仙碱治疗效果不明显转而受氨苯砜治疗的患者应当继续用水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水是不恰当的，很少有炎症超过急性足痛风的病人了，并且秋水导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始秋水碱治疗效果不明显转而苯砜治疗的患者应当继续服用秋水碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水仙素是不恰当的，很少有炎症能超过急性足痛风的病人了，并且秋水仙素能导。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治疗效果不而受氨苯砜治疗的患者应当继续服用秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水仙素是不恰当，很少有炎症能超过急性足痛风了，并且秋水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治疗效果不明显转而受氨苯砜治疗当继续服用秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水仙素当的，很少有炎症能超过急足痛风的病人了，并且秋水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治疗效果明显转而受氨苯砜治疗的患者应当继续服用秋水仙碱。